ETF Holdings Breakdown of ATRC

News associated with ATRC

JPMorgan Chase & Co. Buys 110,039 Shares of AtriCure, Inc. (NASDAQ:ATRC)

JPMorgan Chase & Co. increased its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 43.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 365,183 shares of the medical device company’s stock after acquiring an additional 110,039 shares during the quarter. JPMorgan Chase & Co.’s holdings in AtriCure were worth $11,160,000 […] - 2025-04-14 07:39:04

Corebridge Financial Inc. Reduces Holdings in AtriCure, Inc. (NASDAQ:ATRC)

Corebridge Financial Inc. lowered its stake in shares of AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 7.0% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,535 shares of the medical device company’s stock after selling 1,776 shares during the quarter. Corebridge Financial Inc.’s […] - 2025-04-07 07:32:51

Analysts Set AtriCure, Inc. (NASDAQ:ATRC) Target Price at $51.56

Shares of AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) have earned an average recommendation of “Buy” from the nine analysts that are currently covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average 1-year price objective among brokers that have issued ratings on the stock in the […] - 2025-03-28 06:56:46

Needham & Company LLC Reaffirms “Buy” Rating for AtriCure (NASDAQ:ATRC)

Needham & Company LLC reaffirmed their buy rating on shares of AtriCure (NASDAQ:ATRC – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $51.00 price target on the medical device company’s stock. Several other analysts also recently commented on ATRC. JMP Securities reaffirmed a “market outperform” rating and […] - 2025-03-24 06:34:46

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by Y Intercept Hong Kong Ltd

Y Intercept Hong Kong Ltd lessened its position in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 31.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,997 shares of the medical device company’s stock after selling 6,887 shares during the period. […] - 2025-03-03 08:28:58

Venturi Wealth Management LLC Boosts Position in AtriCure, Inc. (NASDAQ:ATRC)

Venturi Wealth Management LLC increased its stake in AtriCure, Inc. (NASDAQ:ATRC – Free Report) by 1,337.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,257 shares of the medical device company’s stock after buying an additional 2,100 shares during the period. Venturi Wealth […] - 2025-02-25 09:01:02

JPMorgan Chase & Co. Issues Positive Forecast for AtriCure (NASDAQ:ATRC) Stock Price

AtriCure (NASDAQ:ATRC – Free Report) had its price target boosted by JPMorgan Chase & Co. from $40.00 to $51.00 in a research report released on Tuesday morning,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. A number of other equities analysts have also recently issued reports on […] - 2025-02-12 08:32:59

AtriCure, Inc. (NASDAQ:ATRC) Receives $43.38 Average Price Target from Analysts

AtriCure, Inc. (NASDAQ:ATRC – Get Free Report) has earned an average rating of “Buy” from the eight research firms that are covering the company, MarketBeat.com reports. Eight equities research analysts have rated the stock with a buy rating. The average 1 year price target among analysts that have covered the stock in the last year […] - 2025-02-06 07:14:56

ATRC institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value